APA

Grinshpoon A., Moskowitz M., Valevski A., Kreizman A., Palei L., Mar M. & Weizman A. (20121002). Zuclopenthixol, D(1)/D(2) antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients. : European psychiatry : the journal of the Association of European Psychiatrists.

Chicago

Grinshpoon A, Moskowitz M, Valevski A, Kreizman A, Palei L, Mar M and Weizman A. 20121002. Zuclopenthixol, D(1)/D(2) antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients. : European psychiatry : the journal of the Association of European Psychiatrists.

Harvard

Grinshpoon A., Moskowitz M., Valevski A., Kreizman A., Palei L., Mar M. and Weizman A. (20121002). Zuclopenthixol, D(1)/D(2) antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients. : European psychiatry : the journal of the Association of European Psychiatrists.

MLA

Grinshpoon A, Moskowitz M, Valevski A, Kreizman A, Palei L, Mar M and Weizman A. Zuclopenthixol, D(1)/D(2) antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients. : European psychiatry : the journal of the Association of European Psychiatrists. 20121002.